Gareth Peter Gregory

28PUBLICATIONS

119CO-AUTHORS

Haematological tumoursPredictive and prognostic markersGene and molecular therapyAutoimmunityMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|May 16, 2026

Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice.

|Aug 21, 2025

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse.

Mark Waltham, Jonathan Wong, Galina Polekhina

|Jun 27, 2025

Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Jack O'Shaughnessy, Arina Martynchyk, Sze Ting Lee

|Mar 07, 2025

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach.

Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis

|Jan 18, 2025

Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review.

Luke Wang, Eliza Chung, Cameron Wellard

|Aug 19, 2024

Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance.

Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur

Pageof 5

Frequent Collaborators

Stephen S Opat

Eliza A Hawkes

Nada Hamad

Jake Shortt

Constantine Tam

Matthew Ku

Maciej Tatarczuch

Tara Cochrane

Pietro R Di Ciaccio

Judith Trotman

Frequent Collaborators

Stephen S Opat

Eliza A Hawkes

Nada Hamad

Jake Shortt